{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:01:09Z","timestamp":1775113269267,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.7759\/cureus.106305","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:38:22Z","timestamp":1775111902000},"source":"Crossref","is-referenced-by-count":0,"title":["Calcium Disorders in Rheumatic Diseases: An Overlooked Problem With Major Clinical Implications"],"prefix":"10.7759","author":[{"given":"Balakrishnan","family":"Navaneethakrishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopalakrishnan Syamala","family":"Nikhila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910659","article-title":"Vitamin D and rheumatic diseases: a review of clinical evidence","volume":"22","author":"Charoenngam N","year":"2021","unstructured":"Charoenngam N. Vitamin D and rheumatic diseases: a review of clinical evidence. Int J Mol Sci. 2021, 22:10659. 10.3390\/ijms221910659","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-56670-8_11","article-title":"Rheumatic disorders associated with metabolic, endocrine, and hematological diseases","author":"Moutsopoulos HM","year":"2020","unstructured":"Moutsopoulos HM, Zampeli E. Rheumatic disorders associated with metabolic, endocrine, and hematological diseases. Immunology and Rheumatology in Questions. Springer, Cham; 2020. 167-73. 10.1007\/978-3-030-56670-8_11"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3773-6","article-title":"The role of calcium supplementation in healthy musculoskeletal ageing: an expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF)","volume":"28","author":"Harvey NC","year":"2017","unstructured":"Harvey NC, Biver E, Kaufman JM, et al.. The role of calcium supplementation in healthy musculoskeletal ageing: an expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporos Int. 2017, 28:447-62. 10.1007\/s00198-016-3773-6","journal-title":"Osteoporos Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-023-01203-y","article-title":"Case report: disease mechanisms and medical management of calcium nephrolithiasis in rheumatologic diseases","volume":"23","author":"Osman O","year":"2023","unstructured":"Osman O, Manzi S, Wasko MC, Clark BA. Case report: disease mechanisms and medical management of calcium nephrolithiasis in rheumatologic diseases. BMC Urol. 2023, 23:42. 10.1186\/s12894-023-01203-y","journal-title":"BMC Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105725","article-title":"Bone health in children with rheumatic disorders: focus on molecular mechanisms, diagnosis, and management","volume":"23","author":"Di Marcello F","year":"2022","unstructured":"Di Marcello F, Di Donato G, d'Angelo DM, Breda L, Chiarelli F. Bone health in children with rheumatic disorders: focus on molecular mechanisms, diagnosis, and management. Int J Mol Sci. 2022, 23:5725. 10.3390\/ijms23105725","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235867","article-title":"Osteoporosis in rheumatic diseases","volume":"20","author":"Adami G","year":"2019","unstructured":"Adami G, Fassio A, Rossini M, et al.. Osteoporosis in rheumatic diseases. Int J Mol Sci. 2019, 20:5867. 10.3390\/ijms20235867","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-06749-z","article-title":"Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology","volume":"34","author":"Rauf MA","year":"2023","unstructured":"Rauf MA, Kotecha J, Moss K. Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology. Osteoporos Int. 2023, 34:1647-52. 10.1007\/s00198-023-06749-z","journal-title":"Osteoporos Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/1573397114666180320113603","article-title":"Laboratory assessment of patients with suspected rheumatic musculoskeletal diseases: challenges and pitfalls","volume":"15","author":"Carubbi F","year":"2019","unstructured":"Carubbi F, Alunno A, Cipriani P, et al.. Laboratory assessment of patients with suspected rheumatic musculoskeletal diseases: challenges and pitfalls. Curr Rheumatol Rev. 2019, 15:27-43. 10.2174\/1573397114666180320113603","journal-title":"Curr Rheumatol Rev"},{"key":"ref9","article-title":"Prevalence of inflammatory rheumatic diseases in a rheumatologic outpatient clinic: analysis of 12626 cases","volume":"3","author":"Jokar M","year":"2018","unstructured":"Jokar M, Jokar M. Prevalence of inflammatory rheumatic diseases in a rheumatologic outpatient clinic: analysis of 12626 cases. Rheu Res. 2018, 3:21-7.","journal-title":"Rheu Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0022034521990652","article-title":"Calcium signaling in T cells and chronic inflammatory disorders of the oral cavity","volume":"100","author":"Hasiakos S","year":"2021","unstructured":"Hasiakos S, Gwack Y, Kang M, Nishimura I. Calcium signaling in T cells and chronic inflammatory disorders of the oral cavity. J Dent Res. 2021, 100:693-9. 10.1177\/0022034521990652","journal-title":"J Dent Res"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2020.10.005","article-title":"Management of calcium pyrophosphate crystal deposition disease: a systematic review","volume":"51","author":"Parperis K","year":"2021","unstructured":"Parperis K, Papachristodoulou E, Kakoullis L, Rosenthal AK. Management of calcium pyrophosphate crystal deposition disease: a systematic review. Semin Arthritis Rheum. 2021, 51:84-94.","journal-title":"Semin Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S285407","article-title":"Metabolic abnormalities, cardiovascular disease, and metabolic syndrome in adult rheumatoid arthritis patients: current perspectives and clinical implications","volume":"14","author":"Santos-Moreno P","year":"2022","unstructured":"Santos-Moreno P, Rodr\u00edguez-Vargas GS, Mart\u00ednez S, Ibat\u00e1 L, Rojas-Villarraga A. Metabolic abnormalities, cardiovascular disease, and metabolic syndrome in adult rheumatoid arthritis patients: current perspectives and clinical implications. Open Access Rheumatol. 2022, 14:255-67. 10.2147\/OARRR.S285407","journal-title":"Open Access Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S389664","article-title":"Diagnosis and treatment of calcium pyrophosphate deposition (CPPD) disease: a review","volume":"15","author":"Cowley S","year":"2023","unstructured":"Cowley S, McCarthy G. Diagnosis and treatment of calcium pyrophosphate deposition (CPPD) disease: a review. Open Access Rheumatol. 2023, 15:33-41. 10.2147\/OARRR.S389664","journal-title":"Open Access Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.05.015","article-title":"Lung manifestations in the rheumatic diseases","volume":"152","author":"Doyle TJ","year":"2017","unstructured":"Doyle TJ, Dellaripa PF. Lung manifestations in the rheumatic diseases. Chest. 2017, 152:1283-95. 10.1016\/j.chest.2017.05.015","journal-title":"Chest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2019.39.4.345","article-title":"The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases","volume":"39","author":"Gasparyan AY","year":"2019","unstructured":"Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019, 39:345-57. 10.3343\/alm.2019.39.4.345","journal-title":"Ann Lab Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeac134","article-title":"Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging","volume":"23","author":"Mavrogeni S","year":"2022","unstructured":"Mavrogeni S, Pepe A, Nijveldt R, et al.. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2022, 23:e308-22. 10.1093\/ehjci\/jeac134","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/biom12121891","article-title":"Calcium overload and mitochondrial metabolism","volume":"12","author":"Walkon LL","year":"2022","unstructured":"Walkon LL, Strubbe-Rivera JO, Bazil JN. Calcium overload and mitochondrial metabolism. Biomolecules. 2022, 12:1891. 10.3390\/biom12121891","journal-title":"Biomolecules"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1535370216681551","article-title":"Calprotectin in rheumatic diseases","volume":"242","author":"Ometto F","year":"2017","unstructured":"Ometto F, Friso L, Astorri D, Botsios C, Raffeiner B, Punzi L, Doria A. Calprotectin in rheumatic diseases. Exp Biol Med (Maywood). 2017, 242:859-73. 10.1177\/1535370216681551","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00122-X","article-title":"Calcium pyrophosphate deposition disease","volume":"6","author":"Pascart T","year":"2024","unstructured":"Pascart T, Filippou G, Liot\u00e9 F, Sirotti S, Jauffret C, Abhishek A. Calcium pyrophosphate deposition disease. Lancet Rheumatol. 2024, 6:e791-804. 10.1016\/S2665-9913(24)00122-X","journal-title":"Lancet Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012476","article-title":"Hydroxychloroquine in rheumatic autoimmune disorders and beyond","volume":"12","author":"Nirk EL","year":"2020","unstructured":"Nirk EL, Reggiori F, Mauthe M. Hydroxychloroquine in rheumatic autoimmune disorders and beyond. EMBO Mol Med. 2020, 12:e12476. 10.15252\/emmm.202012476","journal-title":"EMBO Mol Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/bs.afnr.2024.04.002","article-title":"Vitamin D and bone health: what vitamin D can and cannot do","volume":"109","author":"Holick MF","year":"2024","unstructured":"Holick MF. Vitamin D and bone health: what vitamin D can and cannot do. Adv Food Nutr Res. 2024, 109:43-66. 10.1016\/bs.afnr.2024.04.002","journal-title":"Adv Food Nutr Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2019.01.003","article-title":"Systemic calprotectin and chronic inflammatory rheumatic diseases","volume":"86","author":"Romand X","year":"2019","unstructured":"Romand X, Bernardy C, Nguyen MV, et al.. Systemic calprotectin and chronic inflammatory rheumatic diseases. Joint Bone Spine. 2019, 86:691-8. 10.1016\/j.jbspin.2019.01.003","journal-title":"Joint Bone Spine"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ph16121718","article-title":"Pathophysiology and therapeutic management of bone loss in patients with critical illness","volume":"16","author":"Kim T","year":"2023","unstructured":"Kim T, Kim H. Pathophysiology and therapeutic management of bone loss in patients with critical illness. Pharmaceuticals (Basel). 2023, 16:1718. 10.3390\/ph16121718","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217998","article-title":"Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study","volume":"80","author":"Filippou G","year":"2021","unstructured":"Filippou G, Scanu A, Adinolfi A, et al.. Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study. Ann Rheum Dis. 2021, 80:261-7. 10.1136\/annrheumdis-2020-217998","journal-title":"Ann Rheum Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/2333794X16685504","article-title":"Pediatric hypovitaminosis D: molecular perspectives and clinical implications","volume":"4","author":"Ariganjoye R","year":"2017","unstructured":"Ariganjoye R. Pediatric hypovitaminosis D: molecular perspectives and clinical implications. Glob Pediatr Health. 2017, 4:2333794X16685504. 10.1177\/2333794X16685504","journal-title":"Glob Pediatr Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222339","article-title":"Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease","volume":"81","author":"Wiebe E","year":"2022","unstructured":"Wiebe E, Huscher D, Schaumburg D, et al.. Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Ann Rheum Dis. 2022, 81:1313-22. 10.1136\/annrheumdis-2022-222339","journal-title":"Ann Rheum Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209233","article-title":"Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative","volume":"75","author":"Baillet A","year":"2016","unstructured":"Baillet A, Gossec L, Carmona L, et al.. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis. 2016, 75:965-73. 10.1136\/annrheumdis-2016-209233","journal-title":"Ann Rheum Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-022-00961-5","article-title":"Vitamin D metabolites: analytical challenges and clinical relevance","volume":"112","author":"Alonso N","year":"2023","unstructured":"Alonso N, Zelzer S, Eibinger G, Herrmann M. Vitamin D metabolites: analytical challenges and clinical relevance. Calcif Tissue Int. 2023, 112:158-77. 10.1007\/s00223-022-00961-5","journal-title":"Calcif Tissue Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190261","article-title":"Predictive utility of cardiovascular risk prediction algorithms in inflammatory rheumatic diseases: a systematic review","volume":"47","author":"Colaco K","year":"2020","unstructured":"Colaco K, Ocampo V, Ayala AP, Harvey P, Gladman DD, Piguet V, Eder L. Predictive utility of cardiovascular risk prediction algorithms in inflammatory rheumatic diseases: a systematic review. J Rheumatol. 2020, 47:928-38. 10.3899\/jrheum.190261","journal-title":"J Rheumatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052871","article-title":"Inflammation and bone metabolism in rheumatoid arthritis: molecular mechanisms of joint destruction and pharmacological treatments","volume":"23","author":"Maeda K","year":"2022","unstructured":"Maeda K, Yoshida K, Nishizawa T, et al.. Inflammation and bone metabolism in rheumatoid arthritis: molecular mechanisms of joint destruction and pharmacological treatments. Int J Mol Sci. 2022, 23:2871. 10.3390\/ijms23052871","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.89794","article-title":"Novel biomarkers and advanced imaging in cardiovascular risk stratification for rheumatic diseases","volume":"17","author":"Shah FH","year":"2025","unstructured":"Shah FH, Agrawal S, Tated RC, Maheta D, Naqvi S. Novel biomarkers and advanced imaging in cardiovascular risk stratification for rheumatic diseases. Cureus. 2025, 17:e89794. 10.7759\/cureus.89794","journal-title":"Cureus"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.05.032","article-title":"Mitral valve dysfunction in patients with annular calcification: JACC review topic of the week","volume":"80","author":"Churchill TW","year":"2022","unstructured":"Churchill TW, Yucel E, Deferm S, Levine RA, Hung J, Bertrand PB. Mitral valve dysfunction in patients with annular calcification: JACC review topic of the week. J Am Coll Cardiol. 2022, 80:739-51. 10.1016\/j.jacc.2022.05.032","journal-title":"J Am Coll Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2741","article-title":"Prevalence of vitamin D deficiency and associated risk factors in the US population (2011-2012)","volume":"10","author":"Parva NR","year":"2018","unstructured":"Parva NR, Tadepalli S, Singh P, et al.. Prevalence of vitamin D deficiency and associated risk factors in the US population (2011-2012). Cureus. 2018, 10:e2741. 10.7759\/cureus.2741","journal-title":"Cureus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0039-z","article-title":"The role of neutrophil extracellular traps in rheumatic diseases","volume":"14","author":"Apel F","year":"2018","unstructured":"Apel F, Zychlinsky A, Kenny EF. The role of neutrophil extracellular traps in rheumatic diseases. Nat Rev Rheumatol. 2018, 14:467-75. 10.1038\/s41584-018-0039-z","journal-title":"Nat Rev Rheumatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy G","year":"2021","unstructured":"Nagy G, Roodenrijs NM, Welsing PM, et al.. EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis. 2021, 80:31-5. 10.1136\/annrheumdis-2020-217344","journal-title":"Ann Rheum Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08911-z","article-title":"Anti-Ro52 autoantibody is common in systemic autoimmune rheumatic diseases and correlating with worse outcome when associated with interstitial lung disease in systemic sclerosis and autoimmune myositis","volume":"63","author":"Chan EK","year":"2022","unstructured":"Chan EK. Anti-Ro52 autoantibody is common in systemic autoimmune rheumatic diseases and correlating with worse outcome when associated with interstitial lung disease in systemic sclerosis and autoimmune myositis. Clin Rev Allergy Immunol. 2022, 63:178-93. 10.1007\/s12016-021-08911-z","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202107-876CME","article-title":"Airway disease in rheumatoid arthritis","volume":"19","author":"Matson SM","year":"2022","unstructured":"Matson SM, Demoruelle MK, Castro M. Airway disease in rheumatoid arthritis. Ann Am Thorac Soc. 2022, 19:343-52. 10.1513\/AnnalsATS.202107-876CME","journal-title":"Ann Am Thorac Soc"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.07.021","article-title":"Rheumatic paraneoplastic syndromes - a clinical link between malignancy and autoimmunity","volume":"186","author":"Manger B","year":"2018","unstructured":"Manger B, Schett G. Rheumatic paraneoplastic syndromes - a clinical link between malignancy and autoimmunity. Clin Immunol. 2018, 186:67-70. 10.1016\/j.clim.2017.07.021","journal-title":"Clin Immunol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000223","article-title":"Coronary microvascular disease: current concepts of pathophysiology, diagnosis and management","volume":"10","author":"Sinha A","year":"2021","unstructured":"Sinha A, Rahman H, Perera D. Coronary microvascular disease: current concepts of pathophysiology, diagnosis and management. Cardiovasc Endocrinol Metab. 2021, 10:22-30. 10.1097\/XCE.0000000000000223","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-021-01800-7","article-title":"Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions","volume":"33","author":"Cruz-Jentoft AJ","year":"2021","unstructured":"Cruz-Jentoft AJ, Romero-Yuste S, Chamizo Carmona E, Nolla JM. Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions. Aging Clin Exp Res. 2021, 33:2929-39. 10.1007\/s40520-021-01800-7","journal-title":"Aging Clin Exp Res"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0000000000000340","article-title":"Vitamin D serum level, disease activity and functional ability in different rheumatic patients","volume":"349","author":"Grazio S","year":"2015","unstructured":"Grazio S, Nagli\u0107 \u0110B, Ani\u0107 B, et al.. Vitamin D serum level, disease activity and functional ability in different rheumatic patients. Am J Med Sci. 2015, 349:46-9. 10.1097\/MAJ.0000000000000340","journal-title":"Am J Med Sci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204531","article-title":"The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients","volume":"74","author":"Arts EE","year":"2015","unstructured":"Arts EE, Fransen J, den Broeder AA, Popa CD, van Riel PL. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. Ann Rheum Dis. 2015, 74:998-1003. 10.1136\/annrheumdis-2013-204531","journal-title":"Ann Rheum Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa531","article-title":"Ankle arthritis - an important signpost in rheumatologic practice","volume":"60","author":"Kiely PD","year":"2021","unstructured":"Kiely PD, Lloyd ME. Ankle arthritis - an important signpost in rheumatologic practice. Rheumatology (Oxford). 2021, 60:23-33. 10.1093\/rheumatology\/keaa531","journal-title":"Rheumatology (Oxford)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex058","article-title":"Rheumatological complications of beta-thalassaemia: an overview","volume":"57","author":"Noureldine MH","year":"2018","unstructured":"Noureldine MH, Taher AT, Haydar AA, Berjawi A, Khamashta MA, Uthman I. Rheumatological complications of beta-thalassaemia: an overview. Rheumatology (Oxford). 2018, 57:19-27. 10.1093\/rheumatology\/kex058","journal-title":"Rheumatology (Oxford)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171389","article-title":"The effect of statin use on mortality in systemic autoimmune rheumatic diseases","volume":"45","author":"Jorge AM","year":"2018","unstructured":"Jorge AM, Lu N, Keller SF, Rai SK, Zhang Y, Choi HK. The effect of statin use on mortality in systemic autoimmune rheumatic diseases. J Rheumatol. 2018, 45:1689-95. 10.3899\/jrheum.171389","journal-title":"J Rheumatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01276-z","article-title":"Platelets as drivers of immunothrombosis in rheumatic diseases","volume":"21","author":"Maugeri N","year":"2025","unstructured":"Maugeri N, Manfredi AA. Platelets as drivers of immunothrombosis in rheumatic diseases. Nat Rev Rheumatol. 2025, 21:478-93. 10.1038\/s41584-025-01276-z","journal-title":"Nat Rev Rheumatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2023.06.002","article-title":"Role of inflammation and immune response in atherosclerosis: mechanisms, modulations, and therapeutic targets","volume":"84","author":"Liu F","year":"2023","unstructured":"Liu F, Wang Y, Yu J. Role of inflammation and immune response in atherosclerosis: mechanisms, modulations, and therapeutic targets. Hum Immunol. 2023, 84:439-49. 10.1016\/j.humimm.2023.06.002","journal-title":"Hum Immunol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000921","article-title":"Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association","volume":"142","author":"Kumar RK","year":"2020","unstructured":"Kumar RK, Antunes MJ, Beaton A, et al.. Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association. Circulation. 2020, 142:e337-57. 10.1161\/CIR.0000000000000921","journal-title":"Circulation"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.06.063","article-title":"Rheumatic heart disease worldwide: JACC scientific expert panel","volume":"72","author":"Watkins DA","year":"2018","unstructured":"Watkins DA, Beaton AZ, Carapetis JR, et al.. Rheumatic heart disease worldwide: JACC scientific expert panel. J Am Coll Cardiol. 2018, 72:1397-416. 10.1016\/j.jacc.2018.06.063","journal-title":"J Am Coll Cardiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140628","article-title":"Calprotectin as a biomarker for rheumatoid arthritis: a systematic review","volume":"42","author":"Abildtrup M","year":"2015","unstructured":"Abildtrup M, Kingsley GH, Scott DL. Calprotectin as a biomarker for rheumatoid arthritis: a systematic review. J Rheumatol. 2015, 42:760-70. 10.3899\/jrheum.140628","journal-title":"J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/469566-calcium-disorders-in-rheumatic-diseases-an-overlooked-problem-with-major-clinical-implications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:38:23Z","timestamp":1775111903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/469566-calcium-disorders-in-rheumatic-diseases-an-overlooked-problem-with-major-clinical-implications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.106305","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}